StreetInsider.com News Articles

FIGS-Developed Healthcare is Human Act Introduced in Congress to Provide Federal Tax Credit for Healthcare Professionals

Fri, 13 Mar 2026 13:00:00 -0400

Bipartisan legislation sponsored by Rep. Claudia Tenney (R-NY) and Rep. Steven Horsford (D-NV) recognizes healthcare professionals for their extraordinary sacrifices and addresses understaffing and burnout

SANTA MONICA, Calif.--(BUSINESS WIRE)-- FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, announced the introduction of the Healthcare is Human Act, a milestone bipartisan bill sponsored by Representatives Claudia Tenney (R-NY) and Steven Horsford (D-NV). Developed in partnership with FIGS, the Tenney-Horsford legislation provides a federal tax credit of up to $6,000 per year to healthcare professionals serving communities most impacted by shortages — directly addressing low pay as a

FIGS-Developed Healthcare is Human Act Introduced in Congress to Provide Federal Tax Credit for Healthcare Professionals

Fri, 13 Mar 2026 13:00:00 -0400

FIGS-Developed Healthcare is Human Act Introduced in Congress to Provide Federal Tax Credit for Healthcare Professionals

Fri, 13 Mar 2026 13:00:00 -0400

FIGS-Developed Healthcare is Human Act Introduced in Congress to Provide Federal Tax Credit for Healthcare Professionals

Fri, 13 Mar 2026 13:00:00 -0400

Figs Inc. (FIGS) PT Raised to $17 at Telsey

Thu, 12 Mar 2026 07:13:06 -0400

(Updated - March 12, 2026 7:13 AM EDT)

Telsey analyst Dana Telsey raised the price target on Figs Inc. (NYSE: FIGS) to $17.00 (from $15.00) while maintaining a Market Perform rating.

The analyst commented: "Raising price target to $17 (from $15). Given continued momentum in the business, we are raising our price target to $17 from $15 previously, which assumes a 28.5x multiple on our two-year forward EBITDA estimate of $100MM, in line with the recent average NTM multiple of 28.3x. Replenishment dynamics and strong brand loyalty supporting customer growth. FIGS’ consumers remain resilient and continue to demonstrate solid fundamentals, supported by

Figs Inc. (FIGS) PT Raised to $17 at Telsey

Thu, 12 Mar 2026 07:13:06 -0400

(Updated - March 12, 2026 7:13 AM EDT)

Telsey analyst Dana Telsey raised the price target on Figs Inc. (NYSE: FIGS) to $17.00 (from $15.00) while maintaining a Market Perform rating.

Form 4 FIGS, Inc. For: Mar 03 Filed by: Oughtred Sarah

Thu, 05 Mar 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260305/26119966.html

Form 4 FIGS, Inc. For: Mar 03 Filed by: Oughtred Sarah

Thu, 05 Mar 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260305/26119966.html

Form 4 FIGS, Inc. For: Mar 03 Filed by: Hasson Heather L.

Thu, 05 Mar 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260305/26119852.html

Form 4 FIGS, Inc. For: Mar 03 Filed by: Hasson Heather L.

Thu, 05 Mar 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260305/26119852.html

Form SCHEDULE 13D/A FIGS, Inc. Filed by: BAMCO INC /NY/

Tue, 03 Mar 2026 17:39:00 -0400

si-local-file:///var/storage/secattach/20260303/26104202.html

Form SCHEDULE 13D/A FIGS, Inc. Filed by: BAMCO INC /NY/

Tue, 03 Mar 2026 17:39:00 -0400

si-local-file:///var/storage/secattach/20260303/26104202.html

Form 4 FIGS, Inc. For: Mar 02 Filed by: Hasson Heather L.

Tue, 03 Mar 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260303/26103801.html

Form 4 FIGS, Inc. For: Mar 02 Filed by: Hasson Heather L.

Tue, 03 Mar 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260303/26103801.html

Form 144 FIGS, Inc. Filed by: Hasson Heather L.

Tue, 03 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260303/26103749.html

Form 144 FIGS, Inc. Filed by: Hasson Heather L.

Tue, 03 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260303/26103749.html

Figs Inc. (FIGS) PT Raised to $14 at Goldman Sachs

Mon, 02 Mar 2026 06:29:32 -0400

Goldman Sachs analyst Brooke Roach raised the price target on Figs Inc. (NYSE: FIGS) to $14.00 (from $7.50) while maintaining a Neutral rating.

Barclays Upgrades Figs Inc. (FIGS) to Overweight

Fri, 27 Feb 2026 09:15:33 -0400

(Updated - February 27, 2026 9:15 AM EST)

Barclays analyst Adrienne Yih upgraded Figs Inc. (NYSE: FIGS) from Equalweight to Overweight with a price target of $17.00.

The analyst comments "Upgrade to OW as FIGS Returns to Core Growth Thesis. FIGS completed its IPO in May 2021 at the peak of healthcare demand for scrubs. Since that time, FIGS has contended with "normalizing" demand trends, a global supply chain glut, a highly promotional competitive backdrop, and tariff-related margin pressure. However, 4Q25 was evidence that FIGS has successfully navigated through all of these challenges, and the merits of the original growth thesis have

Barclays Upgrades Figs Inc. (FIGS) to Overweight

Fri, 27 Feb 2026 09:15:33 -0400

(Updated - February 27, 2026 9:15 AM EST)

Barclays analyst Adrienne Yih upgraded Figs Inc. (NYSE: FIGS) from Equalweight to Overweight with a price target of $17.00.

KeyBanc Upgrades Figs Inc. (FIGS) to Overweight

Fri, 27 Feb 2026 07:28:56 -0400

KeyBanc analyst Ashley Owens upgraded Figs Inc. (NYSE: FIGS) from Sector Weight to Overweight with a price target of $17.00.

For an analyst ratings summary and ratings history on Figs Inc. click here. For more ratings news on Figs Inc. click here.

Shares of Figs Inc. closed at $12.47 yesterday.

Goldman Sachs Upgrades Figs Inc. (FIGS) to Neutral

Fri, 27 Feb 2026 07:20:37 -0400

Goldman Sachs analyst Brooke Roach upgraded Figs Inc. (NYSE: FIGS) from Sell to Neutral with a price target of $14.00.

The analyst comments "We upgrade FIGS to Neutral and raise our 12-month price target to $14 from $7.50 prior. Ahead of 4Q results, our checks indicated sales trends were improving, with strong search engagement and improving net purchase intent scores. However, the magnitude of improvement delivered in 4Q across all key line items and KPIs is much stronger than we forecasted, and management commentary suggests momentum has continued in 1QTD and should support double-digit top line growth in 2026. In combination

Goldman Sachs Upgrades Figs Inc. (FIGS) to Neutral

Fri, 27 Feb 2026 07:20:37 -0400

Goldman Sachs analyst Brooke Roach upgraded Figs Inc. (NYSE: FIGS) from Sell to Neutral with a price target of $14.00.

Figs Inc. (FIGS) PT Raised to $15 at Telsey

Fri, 27 Feb 2026 06:27:18 -0400

(Updated - February 27, 2026 6:27 AM EST)

Telsey analyst Dana Telsey raised the price target on Figs Inc. (NYSE: FIGS) to $15.00 (from $9.00) while maintaining a Market Perform rating.

The analyst commented: "FIGS delivered an impressive quarter to close out FY25, recording significantly stronger topline growth and expense control, resulting in a sizable EBITDA beat. The 33.0% Q4 sales increase was the company’s strongest growth rate in four years, and its first double-digit gain since 3Q23, more than tripling the market’s expectation for a high single digit increase. The topline for the quarter benefitted from over 20% order growth combined

Figs Inc. (FIGS) PT Raised to $15 at Telsey

Fri, 27 Feb 2026 06:27:18 -0400

(Updated - February 27, 2026 6:27 AM EST)

Telsey analyst Dana Telsey raised the price target on Figs Inc. (NYSE: FIGS) to $15.00 (from $9.00) while maintaining a Market Perform rating.

Form S-8 FIGS, Inc.

Thu, 26 Feb 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260226/26072899.html